Skip to main content
Erschienen in: Intensive Care Medicine 1/2017

18.11.2016 | Editorial

Paediatric cardiopulmonary bypass surgery: the challenges of heterogeneity and identifying a meaningful endpoint for clinical trials

verfasst von: V. J. Pappachan, K. L. Brown, S. M. Tibby

Erschienen in: Intensive Care Medicine | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

Survival following paediatric surgery for congenital heart disease (CHD) has improved dramatically over the past two decades; 30-day mortality estimates are now 2.5–4% [1]. However short- and long-term morbidity remain significant issues and hospital length of stay remains unchanged [1]. Both are costly and are linked to poorer long-term neurodevelopmental outcomes [2]. We are now operating on a greater proportion of younger, smaller patients; many with associated extra-cardiac anomalies and chromosomal disorders [3]. Ideally trials should report both immediate perioperative and post-discharge outcomes [4]. …
Literatur
4.
Zurück zum Zitat Brown KL, Wray J, Knowles RL et al (2016) Infant deaths in the UK community following successful cardiac surgery: building the evidence base for optimal surveillance, a mixed-methods study. NIHR J Libr, Southampton (UK) Brown KL, Wray J, Knowles RL et al (2016) Infant deaths in the UK community following successful cardiac surgery: building the evidence base for optimal surveillance, a mixed-methods study. NIHR J Libr, Southampton (UK)
5.
Zurück zum Zitat Guzik TJ, Korbut R, Adamek-Guzik T (2003) Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 54:469–487PubMed Guzik TJ, Korbut R, Adamek-Guzik T (2003) Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 54:469–487PubMed
6.
Zurück zum Zitat Liao JC, Hein TW, Vaughn MW et al (1999) Intravascular flow decreases erythrocyte consumption of nitric oxide. Proc Natl Acad Sci USA 96:8757–8761CrossRefPubMedPubMedCentral Liao JC, Hein TW, Vaughn MW et al (1999) Intravascular flow decreases erythrocyte consumption of nitric oxide. Proc Natl Acad Sci USA 96:8757–8761CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Mellgren K, Friberg LG, Mellgren G et al (1996) Nitric oxide in the oxygenator sweep gas reduces platelet activation during experimental perfusion. Ann Thorac Surg 61:1194–1198CrossRefPubMed Mellgren K, Friberg LG, Mellgren G et al (1996) Nitric oxide in the oxygenator sweep gas reduces platelet activation during experimental perfusion. Ann Thorac Surg 61:1194–1198CrossRefPubMed
9.
Zurück zum Zitat Gianetti J, Del Sarto P, Bevilacqua S et al (2004) Supplemental nitric oxide and its effect on myocardial injury and function in patients undergoing cardiac surgery with extracorporeal circulation. J Thorac Cardiovasc Surg 127:44–50. doi:10.1016/j.jtcvs.2002.08.001 CrossRefPubMed Gianetti J, Del Sarto P, Bevilacqua S et al (2004) Supplemental nitric oxide and its effect on myocardial injury and function in patients undergoing cardiac surgery with extracorporeal circulation. J Thorac Cardiovasc Surg 127:44–50. doi:10.​1016/​j.​jtcvs.​2002.​08.​001 CrossRefPubMed
15.
Zurück zum Zitat Bartlett RH, Roloff DW, Cornell RG et al (1985) Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study. Pediatrics 76:479–487PubMed Bartlett RH, Roloff DW, Cornell RG et al (1985) Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study. Pediatrics 76:479–487PubMed
Metadaten
Titel
Paediatric cardiopulmonary bypass surgery: the challenges of heterogeneity and identifying a meaningful endpoint for clinical trials
verfasst von
V. J. Pappachan
K. L. Brown
S. M. Tibby
Publikationsdatum
18.11.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 1/2017
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-016-4622-y

Weitere Artikel der Ausgabe 1/2017

Intensive Care Medicine 1/2017 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.